Bio Community

Get ready to transform the future of biotechnology at the Bio x AI Hackathon. From March 31, 2025, participants worldwide will compete for a massive $125,000 prize pool, pushing the boundaries of AI-driven BioAgents, scientific tools, and decentralized biotech research.

Bio V1 is the first major upgrade to Bio, bringing more automation and access to early-stage biotech. Our goal is to reshape how biotech breakthroughs are born, enabling global communities of patients, researchers & crypto investors to create user-owned research networks and back brilliant science from day one.

Curetopia, the first Biotech DAO (BioDAO) on Solana, has raised $1.77M to develop treatments in the $1T+ rare disease space. The raise comes on the heels of a recent discovery by Curetopia which could lead to the first-ever treatment for a disease developed by a DeSci project, with proceeds flowing back to the DAO.

Bio V1, launching in the coming weeks, will consist of various components aimed at making early-stage biotech more permissionless and autonomous, including a launchpad, liquidity engine and BioAgents (AI-powered scientific agents integrated with BioDAOs).

Curetopia, the first BioDAO on Solana, is launching today on the Bio Launchpad.‍ The DAO will target the $1T+ rare disease market and is being led by Dr. Ethan O. Perlstein, a Y Combinator alum, Harvard PhD and biotech founder who recently brought a rare disease drug to Phase 3 trials.

January was a historic month for the Bio ecosystem: the BIO token went live on Ethereum and Solana, laying the groundwork for the launch of Bio's new launchpad and liquidity protocol.

It's been a little over a week since BIO went live Jan. 3 on Ethereum & Binance. Then last Thursday Jan. 9, BIO officially bridged to Solana. The focus now turns to deploying Bio's liquidity protocol & launchpad cross-chain (Base included), BIO staking & curation, and launching new BioDAOs.

The BIO Token is going live today, January 3rd, 2025, on Binance and on the Ethereum Mainnet. More blockchains are going live in the coming days and weeks.

A primer on Long COVID Labs, one of the latest additions into the BIO Incubator. Long COVID Labs (LCL) aims to accelerate breakthrough treatments to cure the 100M+ Long COVID patients still struggling to find solutions from Big Pharma.